Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Hongchuan Liu, Huaihuai Dong, Liangjun Guo, Yongsheng Jin & Lihong Liu. (2023) The Effect of Dihydromyricetin on the Pharmacokinetics of Fluconazole in Sprague-Dawley Rat Plasma, Based on High-Performance Liquid Chromatography–Tandem Mass Spectrometry. Drug Design, Development and Therapy 17, pages 2657-2667.
Read now
Read now
Mohitosh Biswas, John Shobana, Pimonpan Jinda & Chonlaphat Sukasem. (2023) Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine. Expert Opinion on Drug Metabolism & Toxicology 19:3, pages 165-174.
Read now
Read now
Feng-Ru Huang, Chen Zhou, Xiao-Yan Zhang, Ye Shen, Hong-Wen Zhang, Yong-Qing Wang & Lu-Ning Sun. (2021) Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies. Xenobiotica 51:10, pages 1199-1206.
Read now
Read now
Irene García-García & Alberto M. Borobia. (2021) Current approaches and future strategies for the implementation of pharmacogenomics in the clinical use of azole antifungal drugs. Expert Opinion on Drug Metabolism & Toxicology 17:5, pages 509-514.
Read now
Read now
Ruth Van Daele, Isabel Spriet & Johan Maertens. (2020) Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation. Expert Opinion on Drug Metabolism & Toxicology 16:7, pages 539-550.
Read now
Read now
Guangting Zeng, Lihong Shi, Huilan Li, Linlin Wang, Miaomiao Zhu, Jia Luo & Zanling Zhang. (2020) Effect of cyclosporine a and polymorphisms in CYP2C19 and ABCC2 on the concentration of voriconazole in patients undergoing allogeneic hematopoietic stem cell transplantation. Xenobiotica 50:5, pages 614-619.
Read now
Read now
Jamie John, Angela Loo, Shawn Mazur & Thomas J. Walsh. (2019) Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 881-895.
Read now
Read now
David Boels, Stéphanie Chhun, Géraldine Meyer, Bénédicte Lelièvre & Vincent Souday. (2019) Clinical consequences related to a defective elimination of clobazam caused by homozygous mutated CYP2C19 allele. Clinical Toxicology 57:8, pages 743-747.
Read now
Read now
Dan Lou, Xiao Cui, Su-Su Bao, Wei Sun, Wen-He Pan, Meng-Chun Chen, Yao-Yao Dong, Guo-Xin Hu, Rui-Jie Chen & Zhe Wang. (2019) Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats. Drug Development and Industrial Pharmacy 45:4, pages 689-693.
Read now
Read now
Articles from other publishers (26)
Sai-li Xie, Xiayan Zhu, Nanyong Gao, Qianmeng Lin, Chaojie Chen, Yun-jun Yang, Jian-ping Cai, Guo-xin Hu & Ren-ai Xu. (2023) Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro. Food and Chemical Toxicology 181, pages 114101.
Crossref
Crossref
Guolin Li, Qinhui Li, Changji Zhang, Qin Yu, Qi Li, Xiaoshi Zhou, Rou Yang, Xuerong Yang, Hailin Liu & Yong Yang. (2023) The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals. Frontiers in Genetics 14.
Crossref
Crossref
Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, Elisabetta Scali, Domenica Scumaci, Michele Pellegrino, Stefano Aquaro, Carmela Saturnino & Maria Stefania Sinicropi. (2023) Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs. Applied Sciences 13:10, pages 6045.
Crossref
Crossref
Amin Rakhshan, Bardia Rahmati Kamel, Ali Saffaei & Maria Tavakoli-Ardakani. (2023) Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study. Iranian Journal of Pharmaceutical Research 22:1.
Crossref
Crossref
Ting Zhao, Hao Shen, Hui-lan Zhang, Jie Feng, Si-ming Liu, Ting-ting Wang, Hong-jian Li & Lu-hai Yu. (2023)
Association of
CYP2C19
,
CYP3A4
and
ABCC2
polymorphisms and voriconazole plasma concentrations in Uygur pediatric patients
. Pharmacogenomics 24:3, pages 141-151.
Crossref
Crossref
Yuhao Fu, Ying Li, Yinling Ma, Xueru He, Xuejiao Xun, Yanjun Cui, Liju Fan & Zhanjun Dong. (2022) Effects of voriconazole and fluconazole on the pharmacokinetics of almonertinib in rats by UPLC–MS/MS. Biomedical Chromatography 37:1.
Crossref
Crossref
Frederic Lamoth & Thierry Calandra. (2022) Pulmonary aspergillosis: diagnosis and treatment. European Respiratory Review 31:166, pages 220114.
Crossref
Crossref
Jianxing Zhou, Zipeng Wei, Baohua Xu, Maobai Liu, Ruichao Xu & Xuemei Wu. (2022) Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database. Frontiers in Pharmacology 13.
Crossref
Crossref
Yishuo Shu, Yinping Shi, Yilei Yang, Zhonghua Dong, Qiaoyan Yi & Haiyan Shi. (2022) Progress of triazole antifungal agent posaconazole in individualized therapy. Journal of Clinical Pharmacy and Therapeutics 47:12, pages 1966-1981.
Crossref
Crossref
Yoshio Takesue, Yuki Hanai, Kazutaka Oda, Yukihiro Hamada, Takashi Ueda, Toshihiko Mayumi, Kazuaki Matsumoto, Satoshi Fujii, Yoshiko Takahashi, Yoshitsugu Miyazaki & Toshimi Kimura. (2022) Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Clinical Therapeutics 44:12, pages 1604-1623.
Crossref
Crossref
Lu Chen, Lixian Li & Wanyi Chen. (2022) Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib. Clinical Pharmacology in Drug Development 11:6, pages 724-733.
Crossref
Crossref
Bereda Gudisa. (2022) Antimycolytic agents: fungistatic and fungicide. Annals of Dermatological Research 6:1, pages 001-009.
Crossref
Crossref
Sumaiya Tabassum & Santhosh Govindaraju. (2022) White LED Light-Mediated Eosin Y-Photocatalyzed One-Pot Synthesis of Novel 1,2,4-Triazol-3-Amines By Sequential Addition. Topics in Catalysis.
Crossref
Crossref
Yi-Chang Zhao, Yang Zou, Jing-Jing Hou, Chen-Lin Xiao, Bi-Kui Zhang, Jia-Kai Li, Da-Xiong Xiang, Indy Sandaradura & Miao Yan. (2021) Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children. Antibiotics 10:12, pages 1542.
Crossref
Crossref
Marwa H. El-Wakil, Mohamed Teleb, Marwa.M. Abu-Serie, Sun Huang, Gerald W. Zamponi & Hesham Fahmy. (2021) Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide. Bioorganic Chemistry 115, pages 105262.
Crossref
Crossref
D. Wilmes, E. Coche, H. Rodriguez-Villalobos & N. Kanaan. (2021) Fungal pneumonia in kidney transplant recipients. Respiratory Medicine 185, pages 106492.
Crossref
Crossref
Jianfu Heng, Qi Tang, Xue Chen, Jingjing Bao, Jun Deng, Yong Chen, Jiao Zhao, Songlin Zhu, Xiaobao Liu, Feng Yang, Yun Jiang, Nong Yang & Kunyan Li. (2021) Evaluation of the pharmacokinetic effects of itraconazole on alflutinib (AST2818): an open-label, single-center, single-sequence, two-period randomized study in healthy volunteers. European Journal of Pharmaceutical Sciences 162, pages 105815.
Crossref
Crossref
Chaodi Luo, Xinglong Zheng, Jing Li, Yongjian Zhang, Tao Shi, Yang Yan & Dan Han. (2021) Pharmacological corrections of the mutant hERG channels by posaconazole. Clinical and Experimental Pharmacology and Physiology 48:6, pages 855-868.
Crossref
Crossref
Katharina R. Beck & Alex Odermatt. (2021) Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess. Molecular and Cellular Endocrinology 524, pages 111168.
Crossref
Crossref
Vanderlan Nogueira Holanda, Welson Vicente da Silva, Pedro Henrique do Nascimento, Sérgio Ruschi Bergamachi Silva, Paulo Euzébio Cabral Filho, Shalom Porto de Oliveira Assis, César Augusto da Silva, Ronaldo Nascimento de Oliveira, Regina Celia Bressan Queiroz de Figueiredo & Vera Lucia de Menezes Lima. (2020) Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations. Bioorganic Chemistry 105, pages 104437.
Crossref
Crossref
Guangting Zeng, Linlin Wang, Lihong Shi, Huilan Li, Miaomiao Zhu, Jia Luo & Zanling Zhang. (2020) Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms. European Journal of Clinical Pharmacology 76:4, pages 515-523.
Crossref
Crossref
Matthew A. Miller & Yee Ming Lee. (2020) Applying Pharmacogenomics to Antifungal Selection and Dosing: Are We There Yet?. Current Fungal Infection Reports 14:1, pages 63-75.
Crossref
Crossref
L. Bernal-Martínez, L. Alcazar Fuoli, B. Miguel-Revilla, A. Carvalho, M. S. Cuétara Garcia, J. Garcia-Rodriguez, C. Cunha, E. Gómez-García de la Pedrosa & A. Gomez-Lopez. (2019) High-Resolution Melting Assay for Genotyping Variants of the CYP2C19 Enzyme and Predicting Voriconazole Effectiveness. Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Crossref
Jarrett R. Amsden & Douglas Slain. (2019) Dosing Antifungals in Obesity: a Literature Review. Current Fungal Infection Reports 13:1, pages 21-32.
Crossref
Crossref
Léa Darnaud, Fabien Lamoureux, Cendrine Godet, Sandrine Pontier, Alexia Debard, Nicolas Venisse, Pauline Martins, Didier Concordet & Peggy Gandia. (2018) Isavuconazole Kinetic Exploration for Clinical Practice. Drugs in R&D 18:4, pages 317-321.
Crossref
Crossref
Claire Calmettes, Frederic Gabriel, Elodie Blanchard, Vincent Servant, Stéphane Bouchet, Nathanael Kabore, Edouard Forcade, Camille Leroyer, Audrey Bidet, Valérie Latrabe, Thibaut Leguay, Stephane Vigouroux, Reza Tabrizi, Dominique Breilh, Isabelle Accoceberry, Manuel Tunon de Lara, Arnaud Pigneux, Noel Milpied & Pierre-Yves Dumas. (2018) Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis. Oncotarget 9:42, pages 26724-26736.
Crossref
Crossref